<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02617888</url>
  </required_header>
  <id_info>
    <org_study_id>362425</org_study_id>
    <nct_id>NCT02617888</nct_id>
  </id_info>
  <brief_title>Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells</brief_title>
  <official_title>The HEART BREAK Study: Effects of Heart Imaging Radiation on DNA Double-Stranded Breaks in Blood Lymphocytes and Hair Follicle Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Walter Reed National Military Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose

        1. To investigate the effects of cardiac imaging radiation on the induction of DNA
           double-strand breaks by enumerating gamma-H2AX foci in blood lymphocytes and plucked
           hair follicle cells.

        2. To estimate whether the use of breast shields in cardiac computed tomographic
           angiography (CCTA) limits the effective radiation exposure of breast tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of the study is to analyze blood and hair samples from patients
      undergoing cardiac imaging to estimate radiation exposure levels as well as their biological
      effects (i.e. to determine the degree of genotoxicity by measuring the amounts of DNA
      double-strand breaks).

      The secondary objective is to investigate whether the use of in-plane breast shielding in
      female patients undergoing CT angiography (CCTA) limits the radiation exposure of breast
      tissue and subsequent DNA damage in blood lymphocytes and hair follicle cells.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging</measure>
    <time_frame>Change from baseline double strand DNA breaks at 30 minutes post-imaging</time_frame>
    <description>The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">228</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Chest Pain</condition>
  <arm_group>
    <arm_group_label>CCTA Breast Shields</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Within female subset, randomization to wearing bismuth breast shield.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CCTA No Breast Shields</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Within female subset, randomization to wearing no bismuth breast shield (standard of care).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observational Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Non-females undergoing CTA and subjects undergoing cardiac catheterization and nuclear medicine testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>CCTA ~ BREAST SHIELDS</intervention_name>
    <description>Breast shield placement (randomized) among women.</description>
    <arm_group_label>CCTA Breast Shields</arm_group_label>
    <other_name>BISMUTH BREAST SHIELDS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male and female adult subjects (age greater than 18 years)

          -  Referred for cardiac computed tomography angiography (CCTA), myocardial perfusion
             scintigraphy (MPS), or diagnostic invasive coronary angiography (ICA).

        Exclusion Criteria:

          -  Female patients that identify themselves as pregnant or have a positive pregnancy test
             prior to cardiac imaging.

          -  History (present or past) of leukemia or lymphoma.

          -  History of radiation therapy

          -  X-ray examination or scintigraphy within the last 72 hours.

          -  History of coronary revascularization (coronary artery bypass grafting or percutaneous
             coronary intervention)

          -  Patients undergoing percutaneous coronary intervention at completion of diagnostic
             left heart catheterization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd C Villines, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WRNMMC</affiliation>
  </overall_official>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2015</study_first_posted>
  <results_first_submitted>November 18, 2016</results_first_submitted>
  <results_first_submitted_qc>November 18, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 19, 2017</results_first_posted>
  <last_update_submitted>June 12, 2017</last_update_submitted>
  <last_update_submitted_qc>June 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Walter Reed National Military Medical Center</investigator_affiliation>
    <investigator_full_name>Todd C. Villines</investigator_full_name>
    <investigator_title>Director of Cardiovascular Research</investigator_title>
  </responsible_party>
  <keyword>radiation</keyword>
  <keyword>cardiac computed tomography</keyword>
  <keyword>CCTA</keyword>
  <keyword>breast shielding</keyword>
  <keyword>Myocardial perfusion scintigraphy</keyword>
  <keyword>MPS</keyword>
  <keyword>Invasive coronary angiography</keyword>
  <keyword>ICA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bismuth</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>101 patients enrolled in intervention arms (breast shields). Other patients in observational arm (not completed analysis).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>CCTA Breast Shields</title>
          <description>Within female subset, randomization to wearing bismuth breast shield.</description>
        </group>
        <group group_id="P2">
          <title>CCTA No Breast Shields</title>
          <description>Within female subset, randomization to not wearing bismuth breast shield (standard of care).</description>
        </group>
        <group group_id="P3">
          <title>Observational</title>
          <description>Non-female patients undergoing coronary CTA, patients undergoing nuclear cardiology studies and invasive coronary angiography.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49">Incomplete due to inadequate double-strand DNA break sample.</participants>
                <participants group_id="P2" count="44">Incomplete due to inadequate double-strand DNA break samples.</participants>
                <participants group_id="P3" count="127"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="7"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CCTA Breast Shields</title>
          <description>Within female subset, randomization to wearing bismuth breast shield.</description>
        </group>
        <group group_id="B2">
          <title>CCTA No Breast Shields</title>
          <description>Within female subset, randomization to not wearing bismuth breast shield (standard of care).</description>
        </group>
        <group group_id="B3">
          <title>Observational Arm</title>
          <description>1. Non-female patients undergoing coronary CTA; 2. Patients undergoing nuclear cardiology stress testing; 3. Patients undergoing invasive coronary angiography.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="127"/>
            <count group_id="B4" value="228"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" spread="14"/>
                    <measurement group_id="B2" value="51" spread="14"/>
                    <measurement group_id="B3" value="51" spread="12"/>
                    <measurement group_id="B4" value="52" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="92"/>
                    <measurement group_id="B4" value="193"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="115"/>
                    <measurement group_id="B4" value="209"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (kg/m^2)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.6" spread="6.3"/>
                    <measurement group_id="B2" value="28.1" spread="4.5"/>
                    <measurement group_id="B3" value="27.3" spread="5"/>
                    <measurement group_id="B4" value="27.9" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Chest circumference (cm)</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.6" spread="11.7"/>
                    <measurement group_id="B2" value="97.8" spread="10.5"/>
                    <measurement group_id="B3" value="97.7" spread="11"/>
                    <measurement group_id="B4" value="97.7" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Current smokers</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Heart rate (beats/min)</title>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.2" spread="5.6"/>
                    <measurement group_id="B2" value="56.2" spread="7.4"/>
                    <measurement group_id="B3" value="64" spread="9"/>
                    <measurement group_id="B4" value="55.7" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging</title>
        <description>The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.</description>
        <time_frame>Change from baseline double strand DNA breaks at 30 minutes post-imaging</time_frame>
        <population>Female patients 18 years or older who were clinically referred to undergo coronary CT angiography between August 2012 and July 2014 at Walter Reed National Military Medical Center (Bethesda, Maryland) were eligible for enrollment.</population>
        <group_list>
          <group group_id="O1">
            <title>No Breast Shields</title>
            <description>Within female subset, randomization to wearing bismuth breast shield or not wearing bismuth breast shield (standard of care).
CCTA: Breast shield placement (randomized) among women.</description>
          </group>
          <group group_id="O2">
            <title>Breast Shields</title>
            <description>Within female subset, randomization to wearing bismuth breast shield or not wearing bismuth breast shield (standard of care).
CCTA: Breast shield placement (randomized) among women.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Excess Double-strand DNA Break Foci Per Cell in Peripheral Blood Samples Post-imaging</title>
          <description>The amount of excess DNA double-strand break foci per cell after cardiac computed tomographic angiography (CCTA) in female patients with and without breast shields, minus the amount of foci prior to CCTA. In addition, changes in DNA double-strand breaks from baseline following cardiac testing in the observational arm is being assessed in an observational manner.</description>
          <population>Female patients 18 years or older who were clinically referred to undergo coronary CT angiography between August 2012 and July 2014 at Walter Reed National Military Medical Center (Bethesda, Maryland) were eligible for enrollment.</population>
          <units>gamma-H2AX foci in blood lymphocytes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="44"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.183" spread="0.114"/>
                    <measurement group_id="O2" value="0.159" spread="0.139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Regression, Linear</method>
            <param_type>Slope</param_type>
            <param_value>0.08</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CCTA Breast Shields</title>
          <description>Within female subset, randomization to wearing bismuth breast shield.</description>
        </group>
        <group group_id="E2">
          <title>CCTA No Breast Shields</title>
          <description>Within female subset, randomization to not wearing bismuth breast shield (standard of care).</description>
        </group>
        <group group_id="E3">
          <title>Observational Arm</title>
          <description>Observational evaluating the dose-related impact of radiation exposure from multiple sources and types on changes in double-stranded DNA breaks.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="127"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Participants were enrolled at one center and using one CT scanner, variable shield types and shield sizes were not studied, and further work is needed to examine tissue-specific responses to radiation and shielding.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Michael K. Cheezum, MD</name_or_title>
      <organization>Ft. Belvoir Community Hospital</organization>
      <phone>571-231-2159</phone>
      <email>Michael.k.cheezum.mil@mail.mil</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

